Terms: = Ovarian cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Diagnosis
24 results:
1. High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma.
Knipprath-Mészáros AM; Tozzi A; Butenschön A; Reina H; Schoetzau A; Montavon C; Heinzelmann-Schwarz V; Manegold-Brauer G
Gynecol Oncol; 2023 Jul; 174():182-189. PubMed ID: 37210928
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma-a large-scale, multi-center, and retrospective study.
Yang X; Yin J; Fu Y; Shen Y; Zhang C; Yao S; Xu C; Xia M; Lou G; Liu J; Lin B; Wang J; Zhao W; Zhang J; Cheng W; Guo H; Guo R; Xue F; Wang X; Han L; Li X; Zhang P; Zhao J; Li W; Dou Y; Wang Z; Liu J; Li K; Chen G; Sun C; Sun P; Lu W; Yao Q
Diagn Pathol; 2023 Jan; 18(1):8. PubMed ID: 36698195
[TBL] [Abstract] [Full Text] [Related]
3. Association of the Affordable Care Act's Medicaid Expansion With 1-Year Survival Among Patients With ovarian cancer.
Bodurtha Smith AJ; Applebaum J; Fader AN
Obstet Gynecol; 2022 Jun; 139(6):1123-1129. PubMed ID: 35675609
[TBL] [Abstract] [Full Text] [Related]
4. RP5-1148A21.3 (lncRP5) exerts oncogenic function in human ovarian carcinoma.
Sun P; Bao A; Hua X; Cao J; Ding Y
Acta Biochim Biophys Sin (Shanghai); 2022 Feb; 54(2):209-219. PubMed ID: 35538027
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours.
Ye S; Wu J; Yao L; He J
J Clin Pathol; 2022 Nov; 75(11):776-781. PubMed ID: 34348985
[TBL] [Abstract] [Full Text] [Related]
6. Detection of ovarian cancer (± neo-adjuvant chemotherapy effects) via atr-FTIR spectroscopy: comparative analysis of blood and urine biofluids in a large patient cohort.
Giamougiannis P; Morais CLM; Rodriguez B; Wood NJ; Martin-Hirsch PL; Martin FL
Anal Bioanal Chem; 2021 Aug; 413(20):5095-5107. PubMed ID: 34195877
[TBL] [Abstract] [Full Text] [Related]
7. Opioid use by cancer status and time since diagnosis among older adults enrolled in the Prostate, Lung, Colorectal, and ovarian screening trial in the United States.
Durham DD; Strassels SA; Pinsky PF
Cancer Med; 2021 Mar; 10(6):2175-2187. PubMed ID: 33638315
[TBL] [Abstract] [Full Text] [Related]
8. Rapid intraoperative diagnosis of gynecological cancer by atr-FTIR spectroscopy of fresh tissue biopsy.
Malonek D; Dekel BZ; Haran G; Reens-Carmel R; Groisman GM; Hallak M; Bruchim I
J Biophotonics; 2020 Sep; 13(9):e202000114. PubMed ID: 32463546
[TBL] [Abstract] [Full Text] [Related]
9. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA
BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725
[TBL] [Abstract] [Full Text] [Related]
10. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
[TBL] [Abstract] [Full Text] [Related]
11. Neoadjuvant Chemotherapy Treatment Modifications in ovarian Carcinoma: The Impact on Surgical Outcome and Progression-free Survival.
Salman L; Ben-Haroush A; Raban O; Yeoshoua E; Sabah G; Jakobson-Setton A; Tsoref D; Eitan R
Am J Clin Oncol; 2019 Jan; 42(1):17-20. PubMed ID: 29889136
[TBL] [Abstract] [Full Text] [Related]
12. Potential of mid-infrared spectroscopy as a non-invasive diagnostic test in urine for endometrial or ovarian cancer.
Paraskevaidi M; Morais CLM; Lima KMG; Ashton KM; Stringfellow HF; Martin-Hirsch PL; Martin FL
Analyst; 2018 Jun; 143(13):3156-3163. PubMed ID: 29878018
[TBL] [Abstract] [Full Text] [Related]
13. The Safety of ovarian Preservation in Stage I Endometrial Endometrioid Adenocarcinoma Based on Propensity Score Matching.
Hou T; Sun Y; Li J; Liu C; Wang Z; Li Y; Lu Y
Comb Chem High Throughput Screen; 2017; 20(7):647-655. PubMed ID: 28413975
[TBL] [Abstract] [Full Text] [Related]
14. [The Advancement of Attenuated Total Reflection Fourier Transform Infrared Technology in Clinical Application].
Zhang XQ; Sun XL; Pan QH; Zhang YF; Xu Z; Guo XY
Guang Pu Xue Yu Guang Pu Fen Xi; 2017 Feb; 37(2):408-11. PubMed ID: 30265462
[TBL] [Abstract] [Full Text] [Related]
15. atr-FTIR spectroscopy coupled with chemometric analysis discriminates normal, borderline and malignant ovarian tissue: classifying subtypes of human cancer.
Theophilou G; Lima KM; Martin-Hirsch PL; Stringfellow HF; Martin FL
Analyst; 2016 Jan; 141(2):585-94. PubMed ID: 26090781
[TBL] [Abstract] [Full Text] [Related]
16. Segregation of ovarian cancer stage exploiting spectral biomarkers derived from blood plasma or serum analysis: atr-FTIR spectroscopy coupled with variable selection methods.
Lima KM; Gajjar KB; Martin-Hirsch PL; Martin FL
Biotechnol Prog; 2015; 31(3):832-9. PubMed ID: 25832726
[TBL] [Abstract] [Full Text] [Related]
17. Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data.
Rubin GP; Saunders CL; Abel GA; McPhail S; Lyratzopoulos G; Neal RD
Br J Cancer; 2015 Feb; 112(4):676-87. PubMed ID: 25602963
[TBL] [Abstract] [Full Text] [Related]
18. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract] [Full Text] [Related]
19. Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer. A cohort study based on 8,507 patients.
Dybvik E; Furnes O; Fosså SD; Trovik C; Lie SA
Acta Orthop; 2014 Dec; 85(6):652-6. PubMed ID: 25238432
[TBL] [Abstract] [Full Text] [Related]
20. Growth differentiation factor-15 as biomarker in uterine sarcomas.
Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
[TBL] [Abstract] [Full Text] [Related]
[Next]
